Indorama Ventures Earnings Deliver Powerful H1 Rebound
Indorama Ventures Earnings Deliver Powerful H1 Rebound
Indorama Ventures entered the second half of 2026 with substantially stronger earnings, improved cash generation and lower leverage. The recovery was supported by healthier market conditions, but it also reflected tighter control over production, inventory and working capital.
The Thailand-based global chemicals producer reported first-half revenue of THB 245.3 billion, an increase of 4% from the same period in 2025. EBITDA climbed 61% to THB 29.7 billion, according to the company’s latest results.
The figures indicate a meaningful improvement from the difficult conditions experienced across the chemicals industry in recent years. However, management has warned that some of the unusually favorable factors seen during the second quarter may not continue at the same strength.
Indorama Ventures earnings at a glance
- Revenue: THB 245.3 billion, up 4% year on year
- EBITDA: THB 29.7 billion, up 61%
- Operating cash flow after maintenance capital expenditure: THB 25.9 billion, up 78%
- First-half net profit attributable to shareholders: THB 3.14 billion
- Net debt-to-equity ratio: 1.56 times
- Second-quarter inventory turnover: 5.0 times
The net-profit result marked a clear turnaround. The company’s reviewed filing with the Stock Exchange of Thailand shows a first-half profit attributable to shareholders of THB 3.14 billion, compared with a THB 1.83 billion loss a year earlier. Second-quarter attributable profit reached THB 5.96 billion, versus a THB 521 million loss in the corresponding 2025 quarter.
These statutory profit figures should not be confused with EBITDA, which excludes interest, taxes, depreciation and amortization and therefore measures a different aspect of operating performance.
Cash generation strengthens the balance sheet
The improvement in cash flow was one of the most important elements of the results.
Operating cash flow after maintenance capital expenditure rose 78% to THB 25.9 billion. This helped Indorama Ventures reduce financial pressure and bring its net debt-to-equity ratio down to 1.56 times.
That ratio reached the company’s 2026 Capital Markets Day target ahead of schedule. Lower leverage may provide greater flexibility if industry spreads weaken or economic conditions become less supportive.
The company credited part of this progress to its IVL 2.0 program. The initiative includes closer coordination between sales and operations, stricter inventory targets and more active management of working capital.
Inventory turnover improved from 4.7 times at the end of 2025 to 5.0 times in the second quarter of 2026. Indorama Ventures also adjusted operating rates to match production more closely with inventory objectives instead of pursuing volume regardless of market conditions. Indorama Ventures earnings
Combined PET leads the improvement
Combined PET was the principal contributor to the earnings recovery. The business benefited from more favorable industry conditions and from Indorama Ventures’ integrated production network.
Its local-for-local model places manufacturing assets closer to customers in major regions. This can reduce exposure to long-distance supply disruptions and help the company respond more quickly to local demand.
Indovida, the company’s packaging operation, maintained its growth momentum through its established market position and organic growth initiatives.
Indovinya produced stronger results across its High Value Applications and Essentials activities, supported by commercial measures intended to improve product mix and margins.
The Fibers division improved sequentially during the second quarter. Stable demand for hygiene products and internal transformation measures provided support, although the Lifestyle and Mobility markets remained weak.
The broad-based improvement is notable because all four operating segments recorded higher second-quarter EBITDA than a year earlier.
Why the outlook remains cautious
Despite the rebound, management is not assuming that second-quarter conditions represent a permanent new baseline.
Indorama Ventures expects some market tailwinds to normalize during the remainder of 2026. Pricing and chemical-product spreads can change quickly in response to energy costs, regional supply, trade flows and demand from downstream industries.
The next test will therefore be whether the company can maintain stronger earnings when external conditions become less favorable.
Management’s stated priorities are to convert earnings into free cash flow, reduce absolute net debt and raise returns on invested capital. Those measures may provide a clearer view of the durability of the recovery than revenue growth alone.
What investors should monitor next
Four indicators will be particularly relevant during the second half:
- Free cash flow: Strong accounting earnings will have greater value if they continue translating into cash.
- Absolute net debt: The debt-to-equity ratio has improved, but further reduction in the underlying debt balance would reinforce the balance sheet.
- Normalized margins: Future results will show how much of the EBITDA improvement came from lasting operational changes rather than temporary market spreads.
- Segment performance: Continued progress in Fibers and resilient results from Indovida and Indovinya would make the recovery less dependent on Combined PET.
The bottom line
Indorama Ventures’ first-half results show a sharp operational and financial recovery. Higher EBITDA, renewed profitability, improved inventory efficiency and stronger cash flow helped the company reach an important leverage target earlier than planned.
The performance is encouraging, but the outlook is not risk-free. Management itself expects exceptional second-quarter support to moderate. Sustainable progress will depend on preserving cash generation and margins under more normal market conditions.
Frequently asked questions
How much revenue did Indorama Ventures report in H1 2026?
Indorama Ventures reported first-half 2026 revenue of THB 245.3 billion, up 4% year on year.
How much did its EBITDA increase?
First-half EBITDA reached THB 29.7 billion, representing a 61% year-on-year increase.
Was Indorama Ventures profitable?
Yes. Its Stock Exchange of Thailand filing reported first-half net profit attributable to shareholders of approximately THB 3.14 billion, compared with a loss in the same period of 2025.
Which division led the recovery?
Combined PET was the main earnings driver, while Indovida, Indovinya and Fibers also contributed to the broader improvement.
What is the principal risk for the second half?
The main concern is the expected normalization of the strong market conditions that supported the second quarter. Cash flow, debt reduction and margins under normalized spreads will consequently be key measures.
Sources
- Indorama Ventures first-half 2026 earnings release
- Stock Exchange of Thailand Q2 management discussion and analysis
- Stock Exchange of Thailand reviewed earnings summary
- Kaohoon International coverage published August 13, 2026
Indorama Ventures PET Strategy Faces Shifting Global Demand
